Skip to main content
Clinical Trials/IRCT20220516054874N11
IRCT20220516054874N11RecruitingPhase 2

Evaluation of the effects of hawthorn extract (Crataegus monogyna) on the hs-CRP level in patients with myocardial infarction

Mashhad University of Medical Sciences0 sites60 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Recruiting
Enrollment
60

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 years to no limit (—)
Sex
All

Inclusion Criteria

  • •Patients with myocardial infarction according to the American College of Heart criteria
  • •Consent to admission to the study
  • •Age more than 18 years old

Exclusion Criteria

  • •Kidney failure under hemodialysis
  • •Severe liver failure with liver enzymes three times more than normal
  • •History of using medicinal products containing Crataegus monogyna extract

Investigators

Similar Trials